Logo for Lobe Sciences Ltd.
LOBE

Lobe Sciences Ltd.

Status
Active
Issued & Outstanding171,560,392
Reserved for Issuance39,369,671
Currency
CSE Index

About

Lobe Sciences Ltd.

Listing date
June 07, 2019

The Company is working to develop psychedelic compounds as therapeutics. Initially the Company will develop psilocybin-based therapeutics in combination with N-acetylcysteine for the treatment of mild traumatic brain injuries and post-traumatic stress disorder and devices for the efficient application of these medications. The Company also owned acquired brands, intellectual property and leases office and production premises to a cannabis processor and retailer which were disposed of on March 5, 2021.